Get the full Zero company profile
Access contacts, investors, buying signals & more
A new player aiming to redefine CRM and sales automation for high-growth companies, Zero, has landed $10.4M in Seed funding. The startup, which is building a powerful and flexible toolkit on a unified customer data layer powered by AI, attracted a diverse group of investors for its initial capital raise.
Primary Venture Partners, Inception Fund, Defiant, Greens, 20VC, and James Hawkins all participated in the round, signaling early confidence in Zero's vision for tomorrow's sales teams.
## 🚀 Breaking Startup News: Zero Secures €8.93 Million to Transform CRM! 🎉 Helsinki-based startup Zero has made headlines by raising an impressive €8.93 million in a Seed round led by New York's Primary Venture Partners.
This funding, bolstered by contributions from Inception Fund, Defiant, Greens, and notable founders from Lovable, Supercell, Langdock, and Silo AI, signals a significant step forward for Zero as it opens to the public today. Founded in 2024 by Tuomo Riekki and Santtu Koivumäki, Zero is pioneering a go-to-market (GTM) operating system tailored for the AI era. By replacing traditional CRM systems a
Zero
A powerful and flexible CRM & sales automation toolkit for tomorrow's high-growth companies. Built on a unified customer data layer powered by AI. Sign up for our waitlist to hear from us soon.
$10.4M Seed
today
AQ Biotech Ltd
AQ Biotech is the leading company implementing an anti-body free screening platform. Its patented phage biosensor method will target early stage screening of prostate and other urinary tract cancers followed by neurodegenerative diseases like Parkinson's disease. Our patented phage biosensor method targets entirely new urine based biomarkers for cancer, neurological disorders, and infectious diseases—with clinical validation already underway in Finland, China and Ghana.
$2.9M Seed
7 days ago
Largest funding rounds in AI on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Nuance Healthcare United States | Unknown | $19.7B | 2y ago |
| 2 |  OpenAI United States | Unknown | $13.0B |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  EnforceShield Lithuania | Seed | $2.0M | today |
| 2 | Zero Finland | Seed | $10.4M | today |
| 3 |
Maculaser Ltd
Maculaser develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration. The core of our innovation is the precise temperature control of the macula during non-damaging laser treatments; a potential game changer in the practise of how major retinal diseases, with over USD 400B direct health care costs, are being treated in the future. Our innovations allow clinicians to perform previously infeasible laser therapy and potentially help millions of people to retain their vision.
$5.1M Unknown
12 days ago
| 2y ago |
| 3 | Anthropic United States | Series f | $13.0B | 1y ago |
| 4 |  AIMAX United Kingdom | Unknown | $10.0B | 2y ago |
| 5 |  Preferred Networks, Inc. Japan | Unknown | ¥10.0B | 1y ago |
 TOPAS Solutions Inc |
| Seed |
| $1.0M |
| today |
| 4 |  Custodea 🇪🇺 The Netherlands | Seed | $406.9K | today |
| 5 |  Aeon Switzerland | Seed | $13.9M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
Primary Venture Partners
OTHER
Inception Fund
VC
Unlock 4 more investors and reach their contacts directly.
Start free trial
EUCLYD
Recently received
dimenso.ai
Recently received
Chift API
Recently received
